ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,542Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 223

$789K Total Retail Price of All Prescriptions

Rank: 17 out of 223

436 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 436 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 436 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 9,826 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
OMEPRAZOLE 527 423 1 3
SIMVASTATIN 451 381 2 1
LEVOTHYROXINE SODIUM 425 319 3 2
LISINOPRIL 332 285 4 4
PRAVASTATIN SODIUM 330 251 5 15
HYDROCODONE-ACETAMINOPHEN 287 182 S3 6 5
AMLODIPINE BESYLATE 275 272 7 6
GABAPENTIN 275 221 7 10
METFORMIN HCL 264 215 9 7
ATORVASTATIN CALCIUM 262 243 10 17
POTASSIUM CHLORIDE 248 182 11 12
FLUOXETINE HCL 244 190 12 24
FUROSEMIDE 242 187 13 9
METOPROLOL SUCCINATE 197 184 14 20
ZOLPIDEM TARTRATE 196 145 15 8
WARFARIN SODIUM 195 191 16 11
TAMSULOSIN HCL 191 178 17 26
TRAMADOL HCL 182 151 18 18
CARVEDILOL 148 127 19 23
GLIMEPIRIDE 145 136 20 30
FLUTICASONE PROPIONATE 131 90 21 27
TORSEMIDE 128 106 22 98
CITALOPRAM HBR 127 106 23 16
LANTUS 124 102 24 34
ALENDRONATE SODIUM 121 118 25 19
FENOFIBRATE 118 80 26 38
ALLOPURINOL 116 103 27 28
METOPROLOL TARTRATE 101 99 28 25
IBUPROFEN 93 51 29 46
LOSARTAN POTASSIUM 92 82 30 14
OXYCODONE HCL 90 54 S2 31 50
RAMIPRIL 89 88 32 86
METFORMIN HCL ER 88 75 33 41
HYDROCHLOROTHIAZIDE 87 83 34 13
CRESTOR 87 84 34 37
OXYBUTYNIN CHLORIDE 86 22 36 75
FENTANYL 86 41 S2 36 91
SPIRONOLACTONE 85 84 38 55
NEXIUM 84 46 39 49
DIOVAN 78 66 40 54
PANTOPRAZOLE SODIUM 77 63 41 45
TRIAMTERENE-HCTZ 75 75 42 39
FINASTERIDE 74 71 43 58
LISINOPRIL-HYDROCHLOROTHIAZIDE 70 68 44 29
PRAMIPEXOLE DIHYDROCHLORIDE 70 66 44 77
DONEPEZIL HCL 69 17 46 36
NAPROXEN 69 65 46 80
CELEBREX 68 63 48 42
LANTUS SOLOSTAR 65 47 49 74
ADVAIR DISKUS 65 51 49 47
CIPROFLOXACIN HCL 64 61 51 53
ISOSORBIDE MONONITRATE ER 63 61 52 110
QUETIAPINE FUMARATE 62 13 53 70
ATENOLOL 60 60 54 32
DIGOXIN 59 48 55 73
SYNTHROID 59 59 55 35
OXYCONTIN 59 34 S2 55 146
PRADAXA 59 40 55 170
TRIAMTERENE-HYDROCHLOROTHIAZID 57 53 59 119
BUPROPION HCL SR 56 32 60 72
CLOPIDOGREL 54 30 61 56
CYMBALTA 51 31 62 40
BENAZEPRIL HCL 51 51 62 57
KLOR-CON M20 50 43 64 67
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 20, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.